Spotlight on: ESMO 2025
From the congress floor: ESMO 2025 in review
October 17-21, 2025 | Berlin, Germany
The European Society for Medical Oncology (ESMO) 2025 took place from 17th to 21st October in Berlin, Germany. The Congress provided a comprehensive educational and scientific programme that sought to foster exchange and debate of translational cancer science, showcase first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions to improve treatment options for patients.
Covering the Congress onsite at Messe Berlin, pharmaphorum interviewed experts in their field and reported from the broad oncological programme of presentations itself. Key areas of focus this year included: prevention, screening, and early diagnosis of cancer; the latest breakthroughs in basic science, and translational and clinical cancer research; clinical perspectives of the scientific advances in cancer biology, diagnostics, and new treatments; and the optimal roles of novel diagnostics and treatments for patients with cancer.
This “Spotlight On” page acts as a hub for updates on ESMO. Check in here for key takeaways, video, and audio content captured live from the Congress floor, and news and write-ups on breaking data releases.
Stay tuned here for pharmaphorum’s reporting from one of the most impactful events on the oncology calendar – featuring voices from across the field and reflections on what the latest findings mean for the future of cancer care.
Reported by Nicole Raleigh
Nicole Raleigh is pharmaphorum’s web editor. Transitioning to the healthcare sector in the last few years, she is an experienced media and communications professional who has worked in print and digital for over 20 years.
Highlights from the past ESMO conferences
About ESMO
Founded in 1975, ESMO is a leading global organisation in oncology, rooted in Europe and representing over 45,000 members worldwide. It serves as a central hub for education, professional development, and integrated cancer care, connecting a diverse community of oncology professionals.
ESMO 2025 will spotlight groundbreaking discoveries and cutting-edge treatments, offering a dynamic space to learn from internationally recognised experts, engage in thought-provoking discussions, and connect with peers driving progress in diagnosis, treatment, and survivorship.